An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

BACKGROUND: Malignant pleural effusion (MPE) is a devastating sequela associated with cancer. Talc pleurodesis is a common treatment strategy for MPE but has been estimated to be unsuccessful in up to 20–50% of patients. Clinical failure of talc pleurodesis is thought to be due to poor dispersion. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Tim N., Deneka, Alexander Y., Chai, Louis, Kanach, Colin, Johal, Priya, Alvarez, Nicolas J., Boumber, Yanis, Golemis, Erica A., Laub, Glenn W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589887/
https://www.ncbi.nlm.nih.gov/pubmed/31234819
http://dx.doi.org/10.1186/s12885-019-5777-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589887/
https://www.ncbi.nlm.nih.gov/pubmed/31234819
http://dx.doi.org/10.1186/s12885-019-5777-z

Ejemplares similares